Search clinical trials for: Aldafermin (NGM282)
Total 14 results
-
NGM Biopharmaceuticals, IncCompletedImpaired Hepatic FunctionUnited States
-
NGM Biopharmaceuticals, IncCompletedImpaired Renal FunctionUnited States
-
NGM Biopharmaceuticals, IncCompletedHealthy MaleUnited States
-
Michael Camilleri, MDNGM Biopharmaceuticals, IncCompletedIrritable Bowel Syndrome With Diarrhea | Bile Acid Malabsorption | Chronic Diarrhea | Functional Diarrhea | Bile Acid Diarrhea | Bile Acid Malabsorption Syndrome Type IIUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedPrimary Biliary CirrhosisUnited States, Australia, New Zealand
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
NGM Biopharmaceuticals, IncCompleted
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
NGM Biopharmaceuticals, IncCompletedPrimary Sclerosing CholangitisUnited States, France, Netherlands, United Kingdom
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedPrimary Biliary CirrhosisUnited States, Australia
-
NGM Biopharmaceuticals, IncCompletedFunctional ConstipationUnited States
-
Merck Sharp & Dohme LLCNovartis PharmaceuticalsCompletedChronic Hepatitis CUnited States